Background: Rheumatoid arthritis (RA) is a common chronic autoimmune disorder characterised by persistent synovitis, typically manifested as symmetric polyarthritis of small hand joints with various extra-articular manifestations. Accurate disease activity measurement is a key component of RA management that facilitates therapeutic optimalization in order to slow down the disease progression and to prevent an irreversible joint damage. The aim of this work was to study the role of candidate serum inflammatory markers and their associations with the disease activity in patients with RA presented by traditional variables of disease activity as well as by musculoskeletal ultrasonography. Results: The first part of our work pointed out relation...
To analyse the accuracy of plasma calprotectin in patients with rheumatoid arthritis (RA) receiving ...
Background: Plasma levels of calprotectin, a major S100 leucocyte protein, are cross-sectionally ass...
RATIONALE: Rheumatoid arthritis (RA) is a chronic autoimmune disease, characterized by pain in affec...
Background: In the past 2 decades, there has been increasing interest in calprotectin. It is release...
Background Calprotectin is a protein released during the activation and turnover of leukocytes. It c...
Clinical remission in some patients with rheumatoid arthritis (RA) may be associated with ongoing sy...
Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) disease activity.In the curre...
<div><p>Background</p><p>Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) dise...
Abstract Background and Objective: Rheumatoid arthritis (RA) is an autoimmune disease defined by ch...
Abstract Background Calprotect...
OBJECTIVES: We aimed to evaluate the correlation between serum calprotectin and clinical and ultraso...
Introduction: Biological markers specifically reflecting pathological processes may add value in the...
AbstractAim of the workAssessment of synovitis in rheumatoid arthritis (RA) is a major issue for pro...
Background Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (D...
Treatment of patients with rheumatoid arthritis (RA) is rarely personalized, since predictors of dis...
To analyse the accuracy of plasma calprotectin in patients with rheumatoid arthritis (RA) receiving ...
Background: Plasma levels of calprotectin, a major S100 leucocyte protein, are cross-sectionally ass...
RATIONALE: Rheumatoid arthritis (RA) is a chronic autoimmune disease, characterized by pain in affec...
Background: In the past 2 decades, there has been increasing interest in calprotectin. It is release...
Background Calprotectin is a protein released during the activation and turnover of leukocytes. It c...
Clinical remission in some patients with rheumatoid arthritis (RA) may be associated with ongoing sy...
Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) disease activity.In the curre...
<div><p>Background</p><p>Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) dise...
Abstract Background and Objective: Rheumatoid arthritis (RA) is an autoimmune disease defined by ch...
Abstract Background Calprotect...
OBJECTIVES: We aimed to evaluate the correlation between serum calprotectin and clinical and ultraso...
Introduction: Biological markers specifically reflecting pathological processes may add value in the...
AbstractAim of the workAssessment of synovitis in rheumatoid arthritis (RA) is a major issue for pro...
Background Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (D...
Treatment of patients with rheumatoid arthritis (RA) is rarely personalized, since predictors of dis...
To analyse the accuracy of plasma calprotectin in patients with rheumatoid arthritis (RA) receiving ...
Background: Plasma levels of calprotectin, a major S100 leucocyte protein, are cross-sectionally ass...
RATIONALE: Rheumatoid arthritis (RA) is a chronic autoimmune disease, characterized by pain in affec...